Clinical trial
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor…
NCT00118703 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00118703 |
|---|---|
| Title | Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis |
| Official title | A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Vasomotor Rhinitis, Rhinitis, Vasomotor |
| Intervention type | Drug |
| Interventions | GW685698X |
| Enrollment | 350 |
| Start date | Jul 1, 2005 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 9, 2006 |
| First posted | Jul 12, 2005 |
| Last update posted | Aug 21, 2017 |
| Countries | Canada, Czechia, Germany, Norway, Puerto Rico, Romania, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: